Our | Products


Vidaza





THERAPEUTIC AREA: Oncology / Hematology + Onco-Hematology
ACTIVE PRINCIPLE: Azacitidine
PRESENTATION: 100 mg x 1 vial
INDICATION:

  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome

COUNTRIES WHERE IT IS MARKETED:
Argentina